Clinical Study Highlights Metaberine's Metabolic Benefits Amid Growing Interest in Berberine
A recent clinical study published in the International Journal of Clinical Trials found that Metaberine, a bio-optimised berberine formulation by Zeus Hygia Lifesciences, improved metabolic health markers including fasting glucose, GLP-1 response, and lipid profiles at a daily dose of 200 mg. Berberine, a plant-derived compound with roots in Ayurveda and traditional Chinese medicine, is gaining popularity for metabolic benefits such as blood sugar and cholesterol control. Experts caution it should not replace prescribed medications despite growing consumer interest.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (68/100). Lens Score 35/100.
Outlets measured: thetribune, thetribune, english. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (55–78/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
english broke this story on 16 Aug, 07:29 am. Other outlets followed.
